AbbVie Inc.

ABBVNYSE

$284.60

Last price · USD

Market cap: $504.9B
P/E: 120.1x
EV / EBITDA: 32.3x
P/S: 8.3x
FCF yield: 3.5%
Div. yield: 2.31%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

AbbVie Inc. balance sheet

Annual · USD millions except per-share data · 43 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Current assets
Cash & cash equivalents	5,229	5,524	12,814	9,201	9,746	-14.4%
Short-term investments	28	31	2	28	84	-24.0%
Cash & short-term investments	5,257	5,555	12,816	9,229	9,830	-14.5%
Net receivables	12,589	10,919	11,155	11,254	9,977	+6.0%
Accounts receivable	12,589	10,919	11,155	11,254	9,977	+6.0%
Inventory	4,951	4,181	4,099	3,579	3,128	+12.2%
Prepaids	0	0	0	0	4,767	—
Other current assets	6,265	4,927	4,932	4,401	226	+129.5%
Total current assets	29,062	25,582	33,002	28,463	27,928	+1.0%
Non-current assets
Property, plant & equipment (net)	6,365	5,134	4,989	4,935	5,110	+5.6%
Goodwill	35,640	34,956	32,293	32,156	32,379	+2.4%
Intangible assets	52,641	60,068	55,610	67,439	75,951	-8.8%
Goodwill & intangible assets	88,281	95,024	87,903	99,595	108,330	-5.0%
Long-term investments	299	279	304	241	277	+1.9%
Other non-current assets	9,953	9,142	8,513	5,571	4,884	+19.5%
Total non-current assets	104,898	109,579	101,709	110,342	118,601	-3.0%
Total assets	133,960	135,161	134,711	138,805	146,529	-2.2%
Current liabilities
Accounts payable	3,592	2,945	3,688	2,934	2,882	+5.7%
Other payables	3,099	0	0	0	0	—
Total payables	6,691	2,945	3,688	2,934	2,882	+23.4%
Short-term debt	8,749	6,804	7,191	4,302	12,673	-8.8%
Other current liabilities	25,630	27,014	25,160	20,931	17,854	+9.5%
Total current liabilities	43,289	38,749	37,841	29,538	35,194	+5.3%
Non-current liabilities
Long-term debt	59,608	60,340	52,167	59,118	64,164	-1.8%
Capital lease obligations (non-current)	711	720	762	771	738	-0.9%
Deferred tax liabilities (non-current)	7,962	7,628	8,633	8,692	8,979	-3.0%
Other non-current liabilities	25,618	24,383	24,911	23,399	22,018	+3.9%
Total non-current liabilities	93,899	93,048	86,473	91,980	95,899	-0.5%
Capital lease obligations	711	720	762	771	738	-0.9%
Total debt	69,068	67,841	60,120	64,191	77,575	-2.9%
Total liabilities	137,188	131,797	124,314	121,518	131,093	+1.1%
Stockholders' equity
Common stock	18	18	18	18	18	0.0%
Retained earnings	(15,493)	(7,900)	(1,000)	4,784	3,127	—
Additional paid-in capital	22,495	21,333	20,180	19,245	18,305	+5.3%
Treasury stock	(9,146)	(8,201)	(6,533)	(4,594)	(3,143)	—
Accumulated other comprehensive income (loss)	(1,144)	(1,925)	(2,305)	(2,199)	(2,899)	—
Total stockholders' equity	(3,270)	3,325	10,360	17,254	15,408	—
Total equity	(3,228)	3,364	10,397	17,287	15,436	—
Minority interest	42	39	37	33	28	+10.7%
Total liabilities & equity	133,960	135,161	134,711	138,805	146,529	-2.2%
Additional fields
Accrued Expenses	2,219	1,986	1,802	1,371	1,785	+5.6%
Net Debt	63,839	62,317	47,306	54,990	67,829	-1.5%
Total Investments	327	310	306	269	361	-2.4%

AbbVie Inc.

ABBVNYSE

$284.60

Last price · USD

Market cap: $504.9B
P/E: 120.1x
EV / EBITDA: 32.3x
P/S: 8.3x
FCF yield: 3.5%
Div. yield: 2.31%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

AbbVie Inc. balance sheet

Annual · USD millions except per-share data · 43 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Current assets
Cash & cash equivalents	5,229	5,524	12,814	9,201	9,746	-14.4%
Short-term investments	28	31	2	28	84	-24.0%
Cash & short-term investments	5,257	5,555	12,816	9,229	9,830	-14.5%
Net receivables	12,589	10,919	11,155	11,254	9,977	+6.0%
Accounts receivable	12,589	10,919	11,155	11,254	9,977	+6.0%
Inventory	4,951	4,181	4,099	3,579	3,128	+12.2%
Prepaids	0	0	0	0	4,767	—
Other current assets	6,265	4,927	4,932	4,401	226	+129.5%
Total current assets	29,062	25,582	33,002	28,463	27,928	+1.0%
Non-current assets
Property, plant & equipment (net)	6,365	5,134	4,989	4,935	5,110	+5.6%
Goodwill	35,640	34,956	32,293	32,156	32,379	+2.4%
Intangible assets	52,641	60,068	55,610	67,439	75,951	-8.8%
Goodwill & intangible assets	88,281	95,024	87,903	99,595	108,330	-5.0%
Long-term investments	299	279	304	241	277	+1.9%
Other non-current assets	9,953	9,142	8,513	5,571	4,884	+19.5%
Total non-current assets	104,898	109,579	101,709	110,342	118,601	-3.0%
Total assets	133,960	135,161	134,711	138,805	146,529	-2.2%
Current liabilities
Accounts payable	3,592	2,945	3,688	2,934	2,882	+5.7%
Other payables	3,099	0	0	0	0	—
Total payables	6,691	2,945	3,688	2,934	2,882	+23.4%
Short-term debt	8,749	6,804	7,191	4,302	12,673	-8.8%
Other current liabilities	25,630	27,014	25,160	20,931	17,854	+9.5%
Total current liabilities	43,289	38,749	37,841	29,538	35,194	+5.3%
Non-current liabilities
Long-term debt	59,608	60,340	52,167	59,118	64,164	-1.8%
Capital lease obligations (non-current)	711	720	762	771	738	-0.9%
Deferred tax liabilities (non-current)	7,962	7,628	8,633	8,692	8,979	-3.0%
Other non-current liabilities	25,618	24,383	24,911	23,399	22,018	+3.9%
Total non-current liabilities	93,899	93,048	86,473	91,980	95,899	-0.5%
Capital lease obligations	711	720	762	771	738	-0.9%
Total debt	69,068	67,841	60,120	64,191	77,575	-2.9%
Total liabilities	137,188	131,797	124,314	121,518	131,093	+1.1%
Stockholders' equity
Common stock	18	18	18	18	18	0.0%
Retained earnings	(15,493)	(7,900)	(1,000)	4,784	3,127	—
Additional paid-in capital	22,495	21,333	20,180	19,245	18,305	+5.3%
Treasury stock	(9,146)	(8,201)	(6,533)	(4,594)	(3,143)	—
Accumulated other comprehensive income (loss)	(1,144)	(1,925)	(2,305)	(2,199)	(2,899)	—
Total stockholders' equity	(3,270)	3,325	10,360	17,254	15,408	—
Total equity	(3,228)	3,364	10,397	17,287	15,436	—
Minority interest	42	39	37	33	28	+10.7%
Total liabilities & equity	133,960	135,161	134,711	138,805	146,529	-2.2%
Additional fields
Accrued Expenses	2,219	1,986	1,802	1,371	1,785	+5.6%
Net Debt	63,839	62,317	47,306	54,990	67,829	-1.5%
Total Investments	327	310	306	269	361	-2.4%